GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (FRA:RVKA) » Definitions » Equity-to-Asset

Cambridge Nutritional Sciences (FRA:RVKA) Equity-to-Asset : 0.68 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Cambridge Nutritional Sciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cambridge Nutritional Sciences's Total Stockholders Equity for the quarter that ended in Sep. 2023 was €10.78 Mil. Cambridge Nutritional Sciences's Total Assets for the quarter that ended in Sep. 2023 was €15.96 Mil. Therefore, Cambridge Nutritional Sciences's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.68.

The historical rank and industry rank for Cambridge Nutritional Sciences's Equity-to-Asset or its related term are showing as below:

FRA:RVKA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.66   Med: 0.79   Max: 0.85
Current: 0.68

During the past 13 years, the highest Equity to Asset Ratio of Cambridge Nutritional Sciences was 0.85. The lowest was 0.66. And the median was 0.79.

FRA:RVKA's Equity-to-Asset is ranked better than
55.94% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs FRA:RVKA: 0.68

Cambridge Nutritional Sciences Equity-to-Asset Historical Data

The historical data trend for Cambridge Nutritional Sciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences Equity-to-Asset Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.72 0.79 0.66 0.69

Cambridge Nutritional Sciences Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.66 0.69 0.69 0.68

Competitive Comparison of Cambridge Nutritional Sciences's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's Equity-to-Asset falls into.



Cambridge Nutritional Sciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cambridge Nutritional Sciences's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=11.279/16.328
=0.69

Cambridge Nutritional Sciences's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=10.777/15.955
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cambridge Nutritional Sciences  (FRA:RVKA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cambridge Nutritional Sciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cambridge Nutritional Sciences (FRA:RVKA) Business Description

Traded in Other Exchanges
Address
One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The company develops, manufacture and market pioneering diagnostic products associated with food sensitivity and gut health. These products enable healthcare practitioners to make informed decisions that can transform their patients' long-term health.

Cambridge Nutritional Sciences (FRA:RVKA) Headlines

No Headlines